METTL14 and hepatocellular carcinoma: In the context of HCC immunotherapy, LPS has also been reported to induce the expression of PD-1 and PD-L1 in mouse tumor tissues via the METTL14/MIR155HG pathway, providing new insights into HCC immunotherapy (Peng et al., 2022).